Pharmacist Involvement in Primary Care Improves Hypertension & Diabetes Measures
Pharmacist involvement in primary care chronic disease co-management of hypertension and T2D improved patients’ blood pressure and hemoglobin A1c.
Read More
Pharmacy
Florida Seeks Patient Prescription Data
THURSDAY, March 6, 2025 (HealthDay News) — Florida’s insurance regulator is demanding...
Read More
Intraoperative Remifentanil, Sufentanil Tied to Poor Postoperative Pain Experience
THURSDAY, March 6, 2025 (HealthDay News) — For patients undergoing elective surgery,...
Read More
No Link Seen Between Preop GLP-1 Receptor Agonist Use and Postop Aspiration Pneumonia
THURSDAY, March 6, 2025 (HealthDay News) — Preoperative glucagon-like peptide-1 receptor...
Read More
Lower Rates of Symptom Rebound Seen After H. Pylori Eradication in GERD
THURSDAY, March 6, 2025 (HealthDay News) — For patients with gastroesophageal reflux disease...
Read More
FDA Expands Indication of Dust Mite Allergy Drug to Include Young Children
WEDNESDAY, March 5, 2025 (HealthDay News) — The U.S. Food and Drug Administration has...
Read More
Long-Term NSAID Use Linked to Reduced Dementia Risk
WEDNESDAY, March 5, 2025 (HealthDay News) — Long-term nonsteroidal anti-inflammatory drug...
Read More
Pericarditis Recurrence Occurs in About 20 Percent of Patients With Lupus
TUESDAY, March 4, 2025 (HealthDay News) — For patients with systemic lupus erythematosus...
Read More
Sotagliflozin Cuts MACE Rate in Patients With T2DM, CKD, CVD Risk Factors
MONDAY, March 3, 2025 (HealthDay News) — For patients with type 2 diabetes, chronic kidney...
Read More
AAN: Prophylactic Zonisamide Effective in Pediatric Migraine
MONDAY, March 3, 2025 (HealthDay News) — For pediatric patients with migraine, prophylactic...
Read More
GLP-1 Receptor Agonist Use Not Linked to Increased Suicide Risk
MONDAY, March 3, 2025 (HealthDay News) — Glucagon-like peptide-1 (GLP-1) receptor agonists...
Read More
AAAAI: Omalizumab Superior to Oral Immunotherapy in Multifood Allergy
MONDAY, March 3, 2025 (HealthDay News) — Omalizumab is superior to oral immunotherapy (OIT)...
Read More
RFK Jr. Says New HHS Decisions No Longer Required to Be Open for Public Comment
MONDAY, March 3, 2025 (HealthDay News) — In a policy statement published today in the...
Read More
Weight Loss After Antiobesity Medication Initiation Lowers Joint Revision Risk
THURSDAY, Feb. 27, 2025 (HealthDay News) — For patients with obesity undergoing joint...
Read More
2017 to 2022 Saw Rise in ED Orders for Buprenorphine for Opioid Use Disorder
THURSDAY, Feb. 27, 2025 (HealthDay News) — Emergency clinicians in California increased...
Read More
Advisory Committee on Immunization Practices February Meeting Postponed
WEDNESDAY, Feb. 26, 2025 (HealthDay News) — The latest meeting of the U.S. Centers for...
Read More
One in Six Patients in Phase 2 Cancer Trials Receive Drug When Eventually Approved
WEDNESDAY, Feb. 26, 2025 (HealthDay News) — One in six patients in phase 2 clinical cancer...
Read More
Guidance Provided for Safe Use of Ketamine
TUESDAY, Feb. 25, 2025 (HealthDay News) — Administration of ketamine for purposes other than...
Read More
Depression Risk Lower With GLP-1 Receptor Agonists Versus DPP-4 Inhibitors in Seniors
MONDAY, Feb. 24, 2025 (HealthDay News) — For older adults with type 2 diabetes (T2D), use of...
Read More
Anifrolumab Tied to Less Organ Damage for Patients With Lupus
THURSDAY, Feb. 20, 2025 (HealthDay News) — For patients with moderately to severely active...
Read More